Profil
Stanley Iyadurai worked as Director-Neuromuscular Genetics Clinic at The Ohio State University.
From 2017 to 2018, worked as Director-Clinical Research & Development at CSL Behring LLC.
From 2018 to 2025, worked as Senior VP-Medical Affairs & Drug Discovery at Catalyst Pharmaceuticals, Inc. Education includes a doctorate from the University of Minnesota.
Ehemalige bekannte Positionen von Stanley Iyadurai
| Unternehmen | Position | Ende |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.12.2025 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Corporate Officer/Principal | 01.07.2018 |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Stanley Iyadurai
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
















